[9]
By notice of motion dated April 18, 2005 ("Disclosure Motion"), Abbott sought an order requiring Novopharm to disclose to Abbott all of the relevant portions of its drug submission. The Disclosure Motion was granted on April 25, 2005 by Prothonotary Lafreni√®re and the resulting order ("Disclosure Order") was made on May 6, 2005.